References
1 Turagam Mohit K, Velagapudi Poonami, Kocheril Abraham G. Atrial fibrillation in athletes. Am. J Cardiol 2012;109:296-302.
2 Claessen G, Colyn E, La Gerche A, Koopman P, Alzand B, Garweg C et al. Long-term endurance sport is a risk factor for development of lone atrial flutter. Heart 2011;97:918-22
3 Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-2962
4 January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr et al. 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1-76
5 Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606
6 Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation of human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32-38
7 Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. NEJM 2012;367:1587-95
8 Asad Z, Yousif A, Khan M, Al-Khatib S, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation. Circ. Arrhtyhm Electrophysiol 2019;12:e007414
9 Berger W, Meulendjiks E, Limpens J, van den Berg N, Neefs J, Driessen A et al. Persistent atrial fibrillation: a systematic review and meta-analysis of invasive strategies. Int J Cardiol 2019;278:137-143
10 Kukendrarajah K, Papageorgious N, Jewell P, Hunter R, Ang R, Schilling R et al. Systematic review and network meta-analysis of atrial fibrillation percutaneous catheter ablation technologies using randomized controlled trials. J Cardiovasc Electrophysiol 2020;31:2192-2205
11 Furlanello F, Lupo P, Pittalis M, Foresti S, Vitali-Serdoz L, Francia P et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol 2008;19:457-62
12 Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation in endurance athletes. Europace 2010;12:30-6
13 Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace 2011;13:1386
14 Decroocq M, Ninni S, Klein C, Machuron F, Verbrugge E, Klug D et al. No impact of sports practice before or after atrial fibrillation ablation on procedure efficacy in athletes: a case-control study. Europace 2019;21:1833-42
15 Mandsager K, Dermot P, Mohamed D, Baranowski B, Saliba W, Tarakji K et al. Outcomes of pulmonary vein isolation in athletes. J Am Coll Cardiol EP 2020;6:1265-74
16 Lavie C, Pandey A, Lau D, Alpert M, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol 2017;70:2022-35
17 Pouwels S, Topal B, Knook M, Celik A, Sundbom M, Ribeiro R et al. Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management. Expter Rev Cardiovasc Ther 2019;17:209-223
18 Middeldorp M, Pathak R, Meredith M, Mehta A, Elliott A, Mahajan R et al. PREVEntion and regressive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. Europace 2018;20:1929-35
19 Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinatthannair R, Lakkireddy D et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace 2018;20:33-42
20 Wilhelm M. Atrial fibrillation in endurance athletes. Eur J Prev Cardiol 2014;21:1040-48
21 Swanson DR. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributore mechanism. Med Hypothesis 2006;66:1085-92
22 Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26:2083-92
23 Calvo N, Brugada J, Sitges M, Mont L. Atrial fibrillation and atrial flutter in athletes. Br J Sports Med 2012;46:i37-i43
24 Pontoppidan J, Nielsen JC, Poulsen SH, Jensen HK, Walfridsson H, Pedersen AK et al. Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomized controlled trial. Herat 2009;95:994-999
25 Mesquita J, Ferreira AM, Cavaco D, Carmo P, Maderia M, Freitas P et al. Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure. Int J Cardiol 2018;259:82-87
26 Lee WC, Fang HY, Chen HC, Chen YL, Tsai TH, Pan KL et al. Additional cavotricuspid isthmus block ablation may not improve the outcome of atrial fibrillation ablation. Pacing Clin Electrophysiol 2019;42:1421-28
27 Romero J, Patel K, Briceno D, Lakkireddy D, Gabr M, Diaz JC et al. Cavotricuspid isthmus line in patients undergoing catheter ablation of atrial fibrillation with or without history of typical atrial flutter: a meta-analysis. J Cardiovasc Electrophysiol 2020;31:1987-95
28 Heidbuchel H, Adami PE, Antz M, Braunschweig F, Delise P, Scherr D et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially atthrythmogenic conditions: Part 1: Supraventricular arrhythmias. Eur J Prev Cardiol 2020; doi: 10.1177/ 2047487320925635